| Feb 28 2020 |
FTC, FDA Team Up Against Anticompetitive Tactics in Biological Product Industry |
MoginRubin |
| Feb 27 2020 |
FDA Permanently Exempts Type III DMFs for Drug Packaging Materials from eCTD Format Requirement |
Keller and Heckman LLP |
| Feb 27 2020 |
Ethical Veganism And The Broadening Range Of Philosophical Beliefs Protected By UK Discrimination Laws |
McDermott Will & Schulte LLP |
| Feb 27 2020 |
FDA Data Shows an Increase in Food Facility Violations for Failing to Develop a Foreign Supplier Verification Program |
Keller and Heckman LLP |
| Feb 27 2020 |
Antitrust Byte: FDA and FTC Join Forces to Promote Biosimilars |
Epstein Becker & Green, P.C. |
| Feb 26 2020 |
FDA Issues More Guidance On Intentional Adulteration Of Food Rule |
Barnes & Thornburg LLP |
| Feb 26 2020 |
Comments on Draft Risk Evaluation for Trichloroethylene Due April 27 |
Bergeson & Campbell, P.C. |
| Feb 26 2020 |
New Jersey Labor Department Issues Companies Stop-Work Orders for Wage Violations |
Jackson Lewis P.C. |
| Feb 26 2020 |
California Federal Judge Certifies Class in “Pure” Honey Labeling Suit |
Keller and Heckman LLP |
| Feb 25 2020 |
Necessity Is The Mother Of Single Reference Anticipation By Inherency |
Foley & Lardner LLP |
| Feb 25 2020 |
CMS Proposes Significant Changes to Medicare Advantage & Part D for 2021 and Beyond, Part 2: CMS Proposes to Codify Supplemental Benefit Rules and Update MLR |
Mintz |
| Feb 25 2020 |
JUUL’s Efforts to Recruit Influencers |
Stark & Stark |
| Feb 24 2020 |
ECHA Urges Companies to Provide More Data on Nanoforms |
Bergeson & Campbell, P.C. |
| Feb 24 2020 |
Anticompetitive Patent-Listing Decision May Clear Patent Thicket for Generic Pharma Industry |
ArentFox Schiff LLP |
| Feb 24 2020 |
Is “Cannabis User” the Next Protected Class in California? |
Jackson Lewis P.C. |
| Feb 24 2020 |
340B Ceiling Price Transparency – HRSA Now Requiring Pharmaceutical Manufacturers to Issue Refunds to Covered Entities for Overcharges |
Mintz |
| Feb 24 2020 |
2019 FDA Precision Medicine Approvals: Progress At FDA |
Foley & Lardner LLP |
| Feb 24 2020 |
Federal Judge Dismisses Amended Complaint Over Dog Food Labeled as “Natural” Containing Trace Levels of Glyphosate Weed Killer |
Keller and Heckman LLP |
| Feb 21 2020 |
EPA Releases Proposed Supplemental SNUR on LCPFAC Chemical Substances |
Bergeson & Campbell, P.C. |
| Feb 21 2020 |
FDA Reopens Comment Period on General Principles for Food Standards Modernization |
Keller and Heckman LLP |
| Feb 21 2020 |
BRAG Biobased Products Blog: February 21, 2020 |
Bergeson & Campbell, P.C. |
| Feb 21 2020 |
California Update: New QR Code Certificate Requirements, Uptick in Enforcement Actions, and the Future of California’s Cannabis Regulators |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 21 2020 |
EPA Publishes Final List of Low-Priority Chemicals for Risk Evaluation under TSCA |
Bergeson & Campbell, P.C. |
| Feb 20 2020 |
Alcoholic Cider and Fermented Fruit Beverages – The Conflict Between Federal and Pennsylvania Law |
Norris McLaughlin P.A. |
| Feb 20 2020 |
JUUL Faces New Lawsuit Over Marketing Tactics |
Stark & Stark |
| Feb 19 2020 |
U.S. DOT Issues Warning Regarding Use Of CBD Products By DOT-Regulated Employees |
Jackson Lewis P.C. |
| Feb 19 2020 |
FDA Releases Third and Final Installment of Intentional Adulteration Draft Guidance |
Keller and Heckman LLP |
| Feb 18 2020 |
Eleventh Circuit Class Action Litigation | Winter 2019/2020 |
Greenberg Traurig, LLP |
| Feb 18 2020 |
Top Trends to Look For in Healthcare in 2020 |
Jackson Lewis P.C. |
| Feb 18 2020 |
Closing the Orphan Drug Act Loophole |
Mintz |
| Feb 17 2020 |
Ninth Circuit Class Action Litigation | Winter 2019/2020 |
Greenberg Traurig, LLP |
| Feb 17 2020 |
Humira: How far can drug makers go to protect their branded market? |
Wiggin and Dana LLP |
| Feb 15 2020 |
Opioid Update: Sixth Circuit Stays National Dispensing Discovery—For Now |
Squire Patton Boggs (US) LLP |
| Feb 14 2020 |
Corteva Announces It Will Cease Production of Embattled Insecticide Chlorpyrifos |
Bergeson & Campbell, P.C. |
| Feb 14 2020 |
Design Patents – Fundamental Additions to Cannabis Intellectual Property Portfolios |
Brinks Gilson & Lione |
